PartsTable TECHNICAL DATA SHEET
NSN 6505-01-309-6639Government record, cited

Sodium Hyaluronate Injection6505-01-309-6639

NSN 6505-01-309-6639 · NIIN 013096639
FSC 6505 — Drugs and Biologicals · FSG 65 — Medical, Dental, and Veterinary Equipment
Government record, cited
Also searched as  6505-01-309-6639 · 6505013096639 · NIIN 013096639 · 01-309-6639 · FSC 6505 Drugs and Biologicals
Nearby stock numbers  ·
Features
  • Sodium Hyaluronate Injection — FSC 6505
  • Administration: INTRAOCULAR
  • Primary Container Content Quantity: 0.550 MILLILITERS
  • Features Provided: STERILE
  • Primary Container Type: SYRINGE
  • Protective Storage Feature: SUBJECT TO DAMAGE BY FREEZING AND REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
  • Active Medicament Medicinal Strength: 10.000 MILLIGRAMS SODIUM HYALURONATE PER MILLILITER
Identification
  • NSN: 6505-01-309-6639
  • NIIN: 013096639
  • FSC: 6505 — Drugs and Biologicals
  • FSG: 65 — Medical, Dental, and Veterinary Equipment
General Description

The Sodium Hyaluronate Injection, cataloged under National Stock Number 6505-01-309-6639, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. Government technical data includes 6 specifications, cited from the U.S. Government catalog. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: EA.

Technical Specifications
ParameterValue
NSN6505-01-309-6639
Item NameSodium Hyaluronate Injection
FSC / FSG6505 / 65 — Drugs and Biologicals
StatusACTIVE
AdministrationINTRAOCULAR
Primary Container Content Quantity0.550 MILLILITERS
Features ProvidedSTERILE
Primary Container TypeSYRINGE
Protective Storage FeatureSUBJECT TO DAMAGE BY FREEZING AND REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
Active Medicament Medicinal Strength10.000 MILLIGRAMS SODIUM HYALURONATE PER MILLILITER
Lifecycle & Compliance
Acquisition StatusACTIVE
DEMIL CodeDEMIL A — No Demilitarization Required
HazardPossible hazard — SDS may be required (DLA HMIC P)
Criticality CodeX
Unit of IssueEA
Cross-Reference Index
No manufacturer part numbers on file in the U.S. Government catalog.
Reference documents
ReferenceMeaning
NDC00016-0310-55 3/9 Design control — primary reference
Johnson & Johnson Surgical Vision, Inc.

Frequently Asked Questions

What is NSN 6505-01-309-6639?

NSN 6505-01-309-6639 is a Sodium Hyaluronate Injection, classified under FSC 6505, Drugs and Biologicals. Status: active.

What are the specifications of 6505-01-309-6639?

Key specifications for 6505-01-309-6639: Administration: INTRAOCULAR; Primary Container Content Quantity: 0.550 MILLILITERS; Features Provided: STERILE; Primary Container Type: SYRINGE. 6 specifications are documented in the U.S. Government catalog.

Is NSN 6505-01-309-6639 hazardous material?

Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.

Sources

U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.

U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.

✓ Data cited from the U.S. Government catalog; commercial cross-references from OEM and certified industry sources.
PartsTable Design LLC · partstable.com